Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Copaxone Approved In Switzerland For Relapse-Remitting Multiple Sclerosis JERUSALEM, ISRAEL -- May 11, 1999-The Swiss Intercantonal Medicines Control office has approved Hoechst Roussel Schweiz’s Copaxone(R) (glatiramer acetate for injection) for the treatment of relapsing-remitting multiple sclerosis (RRMS), marking Copaxone’s first Western European approval. The approved multiple sclerosis therapeutic indication is for the reduction of frequency of relapses and decreasing the progression of disability. Copaxone is the only MS-specific immunomodulator available today. There are approximately 3,500 people with RRMS in Switzerland, of whom only less than one-third are currently being treated. People who suffer from relapsing remitting MS experience relapses - episodes of impaired vision, movement disorders -- followed by remission. These symptoms are caused by attacks on the myelin sheath, the covering which surrounds nerve fibres. The most commonly-observed adverse reactions associated with the use of Copaxone are injection site reactions, flushing and chest pain. Approximately 10 percent of patients exposed to the drug in pre-marketing studies experienced a constellation of symptoms that could include flushing, chest pain, palpitations, anxiety, dyspnea, constriction of the throat and urticaria. These symptoms were invariably transient and self-limited. The cause of MS is unknown and usually strikes people between the ages of 20 and 40. Seventy-three per cent of MS patients are women. Related Links: Copaxone, Hoechst Roussel Schweiz E-mail this page to a friend or colleague! To print, use this version